A New Frontier for Depression Treatment: The Unlikely Ally of Immunotherapy A study published in JAMA Psychiatry suggests that tocilizumab, an anti inflammatory medication used to treat rheumatoid arthritis, may also be effective in reducing symptoms of difficult to treat depression.
This breakthrough offers a glimmer of hope for individuals who have struggled to find relief from conventional treatments. The link between inflammation and depression has long been established.
Research has consistently shown that individuals with depression often exhibit higher levels of inflammatory proteins called cytokines in their blood, particularly interleukin 6 (IL 6).